Welcome to the TRANSEURO consortium website
index

TRANSEURO is a European research consortium with the principal objective to develop an efficacious and safe treatment methodology for Parkinson’s disease suffering patients using fetal cell based treatments. The consortium has gathered international experts including leading clinicians, scientists, industrial partners, ethicists and patients’ representatives who have joined forces in a new round of experimental work and cell therapy trials in Parkinson's Disease.

TRANSEURO is coordinated by Prof. Roger Barker from the Cambridge University and is funded by the 7th Framework Program of the European Commission, Contract number HEALTH-F5-2010-242003.

 

Latest news
     
Consortium Annual Meeting - April 28-30, 2014, Bellagio, Italy   Press release, November 27, 2012 (Swedish) Transplantation av hjärnceller i början på 2013 | more |
 
Consortium Thematic Workshop on " Cells for patients: meeting the GMP challenge"- September 2-3, 2013, Cardiff, UK   "Nytt hopp för parkinsonpatienter" short commentary about the Transeuro consortium aired during evening news in Sweden on November 27, 2012 | more... |
 
Press release, November 30, 2012 Transplant of brain cells for Parkinson's patients In early 2013 | more... |   "Ny metod ska hejda parkinson" - The Transeuro project described in Swedish newspaper SYDSVENSKAN | more... |

 

fp7   EU flag
    Last update: August 2014

 

Home disease objectives contact intranet